Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hepatology
Volume 2014, Article ID 216570, 7 pages
http://dx.doi.org/10.1155/2014/216570
Case Report

Severe Aplastic Anemia following Acute Hepatitis from Toxic Liver Injury: Literature Review and Case Report of a Successful Outcome

1Section of Gastroenterology and Hepatology, Division of Hepatology, Department of Medicine, Temple University School of Medicine, Temple University Health System, 3440 N Broad Street, Kresge Building West No. 209, Philadelphia, PA 19140, USA
2Temple University Hospital, 3401 North Broad Street, Philadelphia, PA 19140, USA
3Division of Gastroenterology and Hepatology, Department of Medicine, Case Western Reserve University School of Medicine, MetroHealth System, Medical Center, 2500 MetroHealth Drive, Cleveland, OH 44109, USA

Received 28 September 2014; Accepted 1 December 2014; Published 22 December 2014

Academic Editor: Melanie Deutsch

Copyright © 2014 Kamran Qureshi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study,” Blood, vol. 70, pp. 1718–1721, 1987.
  2. K. E. Brown, J. Tisdale, A. J. Barrett, C. E. Dunbar, and N. S. Young, “Hepatitis-associated aplastic anemia,” The New England Journal of Medicine, vol. 336, no. 15, pp. 1059–1064, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Wang, M. Tu, R. Fu et al., “The clinical and immune characteristics of patients with hepatitis-associated aplastic anemia in China,” PLoS ONE, vol. 9, no. 5, Article ID e98142, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Locasciulli, A. Bacigalupo, B. Bruno et al., “Hepatitis-associated aplastic anaemia: epidemiology and treatment results obtained in Europe. A report of the EBMT aplastic anaemia working party,” British Journal of Haematology, vol. 149, no. 6, pp. 890–895, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Issaragrisil, C. Sriratanasatavorn, A. Piankijagum et al., “Incidence of aplastic anemia in Bangkok. The Aplastic Anemia Study Group,” Blood, vol. 77, pp. 2166–2168, 1991. View at Google Scholar
  6. L. Hagler, R. A. Pastore, and J. J. Bergin, “Aplastic anemia following viral hepatitis. Report of two fatal cases and literature review,” Medicine, vol. 54, no. 2, pp. 139–164, 1975. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Lorenz and K. Quaiser, “Panmyelopathy following epidemic hepatitis,” Wiener Medizinische Wochenschrift, vol. 105, no. 1, pp. 19–22, 1955. View at Google Scholar · View at Scopus
  8. R. Gonzalez-Casas, L. Garcia-Buey, E. A. Jones, J. P. Gisbert, and R. Moreno-Otero, “Systematic review: hepatitis-associated aplastic anaemia—a syndrome associated with abnormal immunological function,” Alimentary Pharmacology & Therapeutics, vol. 30, no. 5, pp. 436–443, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Khurana and C. A. Dasanu, “Hepatitis associated aplastic anemia: case report and discussion,” Connecticut Medicine, vol. 78, pp. 493–495, 2014. View at Google Scholar
  10. H. Zimmerman, “Hormonal derivatives and related drugs,” in Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver, H. J. Zimmerman, Ed., pp. 555–588, Lippincott, Philadelphia, PA, USA, 2nd edition, 1999. View at Google Scholar
  11. A. L. Vilella, C. Limsuwat, D. R. Williams, and C. F. Seifert, “Cholestatic jaundice as a result of combination designer supplement ingestion,” Annals of Pharmacotherapy, vol. 47, no. 7-8, article e33, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Danan and C. Benichou, “Causality assessment of adverse reactions to drugs—I: a novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries,” Journal of Clinical Epidemiology, vol. 46, no. 11, pp. 1323–1330, 1993. View at Publisher · View at Google Scholar · View at Scopus
  13. J. R. Hibbs, N. Frickhofen, S. J. Rosenfeld et al., “Aplastic anemia and viral hepatitis. Non-A, Non-B, Non-C?” JAMA, vol. 267, no. 15, pp. 2051–2054, 1992. View at Google Scholar
  14. E. Baumelou, M. Guiguet, and J. Y. Mary, “Epidemiology of aplastic anemia in France: a case-control study. I. Medical history and medication use,” Blood, vol. 81, no. 6, pp. 1471–1478, 1993. View at Google Scholar · View at Scopus
  15. R. Safadi, R. Or, Y. Ilan et al., “Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation,” Bone Marrow Transplantation, vol. 27, no. 2, pp. 183–190, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Rauff, M. Idrees, S. A. R. Shah et al., “Hepatitis associated aplastic anemia: a review,” Virology Journal, vol. 8, article 87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. K. G. Ishak and H. J. Zimmerman, “Hepatotoxic effects of the anabolic/androgenic steroids,” Seminars in Liver Disease, vol. 7, no. 3, pp. 230–236, 1987. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Timcheh-Hariri, M. Balali-Mood, E. Aryan, M. Sadeghi, and B. Riahi-Zanjani, “Toxic hepatitis in a group of 20 male body-builders taking dietary supplements,” Food and Chemical Toxicology, vol. 50, no. 10, pp. 3826–3832, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. G. Tzakis, M. Arditi, P. F. Whitington et al., “Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis,” The New England Journal of Medicine, vol. 319, no. 7, pp. 393–396, 1988. View at Publisher · View at Google Scholar · View at Scopus
  20. R. J. Veneri and S. C. Gordon, “Anabolic steroid-induced cholestasis: choleretic response to corticosteroids,” Journal of Clinical Gastroenterology, vol. 10, no. 4, pp. 467–468, 1988. View at Google Scholar · View at Scopus
  21. K. Fukushima, Y. Ueno, H. Kanegane et al., “A case of severe recurrent hepatitis with common variable immunodeficiency,” Hepatology Research, vol. 38, no. 4, pp. 415–420, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. L. D. Notarangelo, A. Fischer, R. S. Geha et al., “Primary immunodeficiencies: 2009 update,” Journal of Allergy and Clinical Immunology, vol. 124, no. 6, pp. 1161–1178, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Cengiz, N. Turhan, O. F. Yolcu, and S. Yilmaz, “Hepatitis associated with aplastic anemia: do CD8(+) Kupffer cells have a role in the pathogenesis?” Digestive Diseases and Sciences, vol. 52, no. 9, pp. 2438–2443, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. W. A. Kagan, J. A. Ascensão, R. N. Pahwa et al., “Aplastic anemia: presence in human bone marrow of cells that suppress myelopoiesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 73, no. 8, pp. 2890–2894, 1976. View at Publisher · View at Google Scholar · View at Scopus
  25. E. E. Solomou, K. Keyvanfar, and N. S. Young, “T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia,” Blood, vol. 107, no. 10, pp. 3983–3991, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Lu, A. Basu, J. J. Melenhorst, N. S. Young, and K. E. Brown, “Analysis of T-cell repertoire in hepatitis-associated aplastic anemia,” Blood, vol. 103, no. 12, pp. 4588–4593, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Ikawa, R. Nishimura, R. Kuroda et al., “Expansion of a liver-infiltrating cytotoxic T-lymphocyte clone in concert with the development of hepatitis-associated aplastic anaemia,” British Journal of Haematology, vol. 161, no. 4, pp. 599–602, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Doney, W. Leisenring, R. Storb, and F. R. Appelbaum, “Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy,” Annals of Internal Medicine, vol. 126, no. 2, pp. 107–115, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Pongtanakul, P. K. Das, K. Charpentier, and Y. Dror, “Outcome of children with aplastic anemia treated with immunosuppressive therapy,” Pediatric Blood and Cancer, vol. 50, no. 1, pp. 52–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. N. S. Young, P. Scheinberg, and R. T. Calado, “Aplastic anemia,” Current Opinion in Hematology, vol. 15, no. 3, pp. 162–168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. K. Davies and E. C. Guinan, “An update on the management of severe idiopathic aplastic anaemia in children,” British Journal of Haematology, vol. 136, no. 4, pp. 549–564, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. W. J. Savage, P. A. DeRusso, L. M. Resar et al., “Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide,” Pediatric Blood and Cancer, vol. 49, no. 7, pp. 947–951, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Osugi, H. Yagasaki, M. Sako et al., “Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia,” Haematologica, vol. 92, no. 12, pp. 1687–1690, 2007. View at Publisher · View at Google Scholar · View at Scopus